Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PEG 3350 Laxatives: FDA Allows Firms 6 Months To Make Their Case For Rx Products

Apr 17 2018

• By Malcolm Spicer

Related Content

FDA Rejects Arguments On Keeping Rx PEG Products Available

Jun 02 2014

Rx PEG Firms Give FDA Deadline Before Asking Court To Delay ANDA Withdrawals

Apr 12 2018

Related Companies

Esteve Pharmaceuticals, S.A.

Lannett Company, Inc.

Perrigo Company PLC

Bayer AG

Perrigo Company PLC

Merck & Co., Inc.

Additional Topics

United States Prescription To OTC Switch Regulation Safety Ingredients OTC Drugs Gastrointestinal Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window